ARCHIVES

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

Panel Says NIH Must Devise Means For Early Release Of Trials Data

January 25, 1991

DCPC advisors OK New Grant Programs In Tobacco, Rural Area

November 12, 1993

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

Many Colorectal Cancer Survivors Do Not Receive Recommended Follow-up Care

September 26, 2008

Abstracts Of Papers From Gynecologic Oncology Conference

October 17, 1975

Hayloc, Krebs Lead Oncology Nurses

May 16, 1997